Search

Author/Creator Okamoto, Rumiko

1. Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study*. Issue 1 (2nd January 2019)

Authors:
Robak, Tadeusz; Huang, Huiqiang; Jin, Jie; Zhu, Jun; Liu, Ting; Samoilova, Olga; Pylypenko, Halyna; Verhoef, Gregor; Siritanaratkul, Noppadol; Osmanov, Evgenii; Pereira, Juliana; Mayer, Jiri; Hong, Xiaonan; Okamoto, Rumiko; Pei, Lixia; Rooney, Brendan; van de Velde, Helgi; Cavalli, Franco
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 1(2019)
Page Start:
172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study. Issue 1 (2nd January 2019)

Authors:
Robak, Tadeusz; Huang, Huiqiang; Jin, Jie; Zhu, Jun; Liu, Ting; Samoilova, Olga; Pylypenko, Halyna; Verhoef, Gregor; Siritanaratkul, Noppadol; Osmanov, Evgenii; Pereira, Juliana; Mayer, Jiri; Hong, Xiaonan; Okamoto, Rumiko; Pei, Lixia; Rooney, Brendan; van de Velde, Helgi; Cavalli, Franco
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 1(2019)
Page Start:
172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study. Issue 11 (November 2018)

Authors:
Robak, Tadeusz; Jin, Jie; Pylypenko, Halyna; Verhoef, Gregor; Siritanaratkul, Noppadol; Drach, Johannes; Raderer, Markus; Mayer, Jiri; Pereira, Juliana; Tumyan, Gayane; Okamoto, Rumiko; Nakahara, Susumu; Hu, Peter; Appiani, Carlos; Nemat, Sepideh; Cavalli, Franco
Journal:
Lancet oncology
Issue:
Volume 19:Issue 11(2018)
Page Start:
1449
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Meta‐analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy‐induced anemia and mortality: Individual patient data from Japanese randomized, placebo‐controlled trials. Issue 4 (15th March 2013)

Authors:
Ohashi, Yasuo; Uemura, Yukari; Fujisaka, Yasuhito; Sugiyama, Toru; Ohmatsu, Hironobu; Katsumata, Noriyuki; Okamoto, Rumiko; Saijo, Nagahiro; Hotta, Tomomitsu
Journal:
Cancer science
Issue:
Volume 104:Issue 4(2013:Apr.)
Page Start:
481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis. Issue 1 (2nd January 2018)

Authors:
Tomita, Naoto; Yokoyama, Masahiro; Yamamoto, Wataru; Watanabe, Reina; Shimazu, Yutaka; Masaki, Yasufumi; Tsunoda, Saburo; Hashimoto, Chizuko; Murayama, Kayoko; Yano, Takahiro; Okamoto, Rumiko; Kikuchi, Ako; Tamura, Kazuo; Sato, Kazuya; Sunami, Kazutaka; Shibayama, Hirohiko; Takimoto, Rishu; Ohshi...
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 1(2018)
Page Start:
97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗